In this study, for the first time we investigated the changes in the PTPRG protein level in CML patients at the State of Qatar determined by flow cytometry using a unique monoclonal antibody against the external domain of PRPRG. The gene discussed is PTPRG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.